Plasma postdexamethasone cortisol levels in schizoaffective disorder

Area of Science:

• Neuroscience
• Psychiatry
• Endocrinology

Background:

• Hypothalamic-pituitary-adrenal (HPA) axis dysregulation is implicated in major depressive disorder (MDD).
• Understanding HPA axis function in schizoaffective disorder (SAD) is crucial for differential diagnosis and treatment.
• Delusional features in depression may be associated with distinct biological markers.

Purpose of the Study:

• To compare the degree of HPA axis dysregulation in patients with schizoaffective disorder, major depressive disorder, and major depressive disorder with delusional features.
• To investigate potential differences in HPA axis activity and its correlates across these diagnostic groups.

Main Methods:

• Dexamethasone suppression test (DST) was administered to assess HPA axis function.
• Plasma cortisol levels were measured post-dexamethasone.
• Correlations between cortisol levels and clinical variables (illness severity, age, weight loss) were analyzed.

Main Results:

• Nonsuppression to dexamethasone was similar across all three diagnostic groups (SAD, MDD, delusional depression).
• Maximum post-dexamethasone cortisol was higher in delusional depressives compared to MDD and SAD patients.
• Correlations between cortisol levels and illness severity were observed in MDD and SAD patients, with additional associations with age and weight loss in MDD patients.

Conclusions:

• While HPA axis dysregulation is prevalent in MDD, delusional depression, and SAD, the underlying contributing factors may differ.
• HPA axis activity in SAD shows associations with illness severity, suggesting distinct pathophysiological mechanisms compared to MDD.